A randomized, controlled trial of fingolimod in Japanese MS

Gilenya, or Fingolimod, is the first approved oral disease modifying drug for MS.

A randomized, controlled trial of fingolimod in Japanese MS

Postby MSUK » Mon Feb 27, 2012 1:18 am

A randomized, controlled trial of fingolimod (FTY720) in Japanese MS patients

Image


Abstract
Background: Fingolimod (FTY720) has previously shown clinical efficacy in phase II/III studies of predominantly Caucasian populations with multiple sclerosis (MS).

Objectives: To report six-month efficacy and safety outcomes in Japanese patients with relapsing MS treated with fingolimod.... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1309
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2157
Joined: Wed Oct 14, 2009 3:00 pm

Advertisement

Return to Gilenya

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service